Business

Johnson & Johnson exec signs on for Algorae AI drug development

November 28, 202428 views0

Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug combinations recommended by AI to tackle hard to beat diseases.

Business / Companies

Brisbane Times – Business

ASX Runners of the Week: Wide Open, Pacific, Forbidden Foods & Olympio

This week’s Bulls N’ Bears ASX Runner of the Week is… Wide Open. It surged ...

1 day ago

Business

Minority government would be ‘terrible’ for the economy, warns Gerry Harvey

Consumers are holding up better than expected, said the outspoken 85-year-old retail billionaire, with premium ...

1 day ago

Business

Star is seconds from oblivion and its luck may have run out

The casino operator is still clinging onto hope of a last-minute reprieve, but the Doomsday ...

1 day ago

Now Reading

Johnson & Johnson exec signs on for Algorae AI drug development

1min read

0 %

Johnson & Johnson exec signs on for Algorae AI drug development

Watch out! Crony capitalism is coming to America

$2.5 million cash boost fires up Great Southern WA gold hunt

Leave a reply Cancel reply

More in:Business

ASX Runners of the Week: Wide Open, Pacific, Forbidden Foods & Olympio

Minority government would be ‘terrible’ for the economy, warns Gerry Harvey

Star is seconds from oblivion and its luck may have run out

Posts List

Star goes into trading halt with board unsure of its survival

Antoinette Lattouf v ABC LIVE updates: Ita Buttrose ‘influenced’ former presenter’s axing, barrister says as closing submissions continue

Brisbane news live: Council hopeful pay deal will end service disruptions

Categories

The Inland Report

Share

You may also like

Leave a reply Cancel reply

More in:Business

Posts List

Categories

Latest Posts